ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,770Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 336

$1.1M Total Retail Price of All Prescriptions

Rank: 30 out of 336

856 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 856 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

24% of this provider’s 856 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 15,065 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
FUROSEMIDE 955 707 1 4
OMEPRAZOLE 851 654 2 3
POTASSIUM CHLORIDE 751 554 3 9
SIMVASTATIN 659 488 4 5
HYDROCODONE-ACETAMINOPHEN 659 373 S3 4 2
CLONIDINE HCL 573 396 6 32
LEVOTHYROXINE SODIUM 508 402 7 7
METOPROLOL TARTRATE 480 315 8 16
CARVEDILOL 394 278 9 13
AMLODIPINE BESYLATE 389 333 10 1
CLOPIDOGREL 384 300 11 28
CIPROFLOXACIN HCL 373 256 12 55
WARFARIN SODIUM 345 261 13 17
GABAPENTIN 338 259 14 11
PLAVIX 289 221 15 37
AMIODARONE HCL 274 200 16 117
HYDROCHLOROTHIAZIDE 266 223 17 12
ENALAPRIL MALEATE 266 183 17 60
CITALOPRAM HBR 253 193 19 21
GLYBURIDE 247 167 R 20 76
HYDRALAZINE HCL 245 145 21 53
DONEPEZIL HCL 244 220 22 27
LISINOPRIL 243 178 23 6
ATORVASTATIN CALCIUM 241 183 24 14
NIFEDIPINE ER 240 178 25 87
NAMENDA 227 205 26 39
METFORMIN HCL 214 140 27 8
TRAMADOL HCL 197 166 28 20
TAMSULOSIN HCL 177 136 29 38
PRAVASTATIN SODIUM 148 107 30 10
MELOXICAM 142 100 31 19
DIOVAN 142 115 31 31
ALLOPURINOL 141 95 33 30
NAPROXEN 135 126 34 80
KLOR-CON 10 132 95 35 75
CRESTOR 130 111 36 25
AGGRENOX 129 105 37 133
ZOLPIDEM TARTRATE 126 68 38 18
POLYETHYLENE GLYCOL 3350 124 115 39 68
AMLODIPINE BESYLATE-BENAZEPRIL 119 88 40 47
METOCLOPRAMIDE HCL 113 39 41 123
NOVOLOG MIX 70-30 111 63 42 189
JANUVIA 97 51 43 67
ISOSORBIDE MONONITRATE ER 96 78 44 44
SERTRALINE HCL 95 55 45 33
FLUDROCORTISONE ACETATE 94 87 46 332
DIGOXIN 92 62 47 50
MIRTAZAPINE 92 73 47 66
PROMETHAZINE HCL 89 52 R 49 99
WELCHOL 89 67 49 195
SYNTHROID 89 65 49 43
ZETIA 89 81 49 74
FAMOTIDINE 89 77 49 73
KLOR-CON 8 88 62 54 237
LIPITOR 87 76 55 62
PANTOPRAZOLE SODIUM 83 52 56 40
LOVASTATIN 83 64 56 34
MECLIZINE HCL 81 72 58 96
AMITRIPTYLINE HCL 81 57 R 58 57
METHYLPREDNISOLONE 79 65 60 104
PREDNISONE 79 51 60 48
DIOVAN HCT 78 56 62 41
ADVAIR DISKUS 78 67 62 82
ATENOLOL 75 66 64 26
LYRICA 69 47 65 70
PHENYTOIN SODIUM EXTENDED 69 47 65 97
CYMBALTA 68 20 67 52
GEMFIBROZIL 67 44 68 115
NEXIUM 66 33 69 24
SPIRIVA 64 44 70 88
LEVEMIR 62 35 71 149
MEGESTROL ACETATE 62 58 R 71 110
GLYBURIDE-METFORMIN HCL 61 35 R 73 78
CARBIDOPA-LEVODOPA 61 49 73 150
GLIPIZIDE 61 29 73 71
HYDROXYCHLOROQUINE SULFATE 59 41 76 176
METOPROLOL SUCCINATE 59 40 76 15
ESCITALOPRAM OXALATE 57 46 78 69
CELEBREX 57 48 78 105
TRIAMTERENE-HCTZ 57 51 78 35
NOVOLOG 56 28 81 135
RANITIDINE HCL 56 37 81 36
KLOR-CON M20 53 38 83 51
BENAZEPRIL HCL 50 35 84 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.